Clinical trial
Comparison of the Generic and Original Formulation of Clopidogrel Regarding the Potency of Platelet Inhibition in Patients After PCI
NCT01147133 is registered in ClinicalTrials.gov with University of Pecs as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Generic and Original Formulation of Clopidogrel Regarding the Potency of Platelet Inhibition in Patients After PCI
- Lead sponsor
- University of Pecs
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- May 31, 2010
- Enrollment
- 75 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary heart disease, percutaneous coronary intervention